| | | | | Factors predicting bladder TCC survival identified
| | | By
Cheryl Guttman Krader
| | | A multi-institutional retrospective analysis has identified five variables that independently predict cancer-specific survival in patients with nonmetastatic transitional cell carcinoma of the upper urinary tract.
| | | Outcomes favor extended PLND in radical cystectomy
| | | By
Cheryl Guttman Krader
| | | Results of a retrospective, inter-institutional study comparing outcomes of patients with urothelial carcinoma of the bladder highly favor the use of an extended template for bilateral pelvic lymph node dissection (PLND) when performing radical cystectomy.
| | | Study documents features, outcomes of upper tract TCC
| | | By
Cheryl Guttman Krader
| | | The primary message from a study evaluating long-term urothelial recurrence and disease-specific survival after radical nephroureterectomy for upper tract transitional cell carcinoma is that there remains a critical need for better methods to enable early diagnosis.
| | | Study supports early cystectomy for pT1G3 TCC
| | | By
Fred Gebhart
| | | It may be time to update treatment guidelines for transitional cell carcinoma.
| | | Two-step TURB improves superficial TCC outcomes
| | | By
Fred Gebhart
| | | A two-step transurethral resection (TURB) procedure in patients with superficial transitional bladder cancer, already part of practice guidelines in Germany, appears to improve patient outcomes by identifying positive tumor beds that may require a second TURB.
| | | Adjuvant BCG offers no benefit in upper tract TCC
| | | By
Cheryl Guttman Krader
| | | Adjuvant bacillus Calmette-Guerin appears to provide no benefit for improving the oncologic outcome of patients with upper tract transitional cell carcinoma undergoing nephroureterectomy.
| | | Endoscopy may be effective in select TCC patients
| | | By
Scott Tennant
| | | Patients with a relatively small volume of low-grade upper tract transitional cell carcinoma can be managed by purely endoscopic means over a long period of time.
| |
| | | | | | | | | | Metabolic syndrome and LUTS: An emerging relationship
| | | By
Kevin T. McVary, MD
,
Shane Russell, MD, MPH
| | | Increasing evidence has recently pointed toward a relationship between LUTS secondary to BPH and the presence of metabolic syndrome. This relationship has been supported by recent epidemiologic findings.
| |
| | | | ETFs offer some advantages over mutual funds
| | | By
Joel M. Blau, CFP
| | | Exchange-traded funds (ETFs) are investment portfolios that trade like stocks on an exchange.
| | | Time to add a partner to your practice?
| | | By
Judy Capko
| | | Busy urologists seeking relief from the demands and responsibilities of running a practice are likely to entertain the possibility of bringing in a partner. But a rush to judgment can lead to mistakes that might otherwise be avoided.
| | | Ambulatory surgery centers: To build or not to build?
| | | By
Ray Painter, MD
,
Mark Painter
| | | The shift of surgical procedures from the hospital to physician-owned outpatient facilities has been the prevailing trend over the past 2 decades and will continue into the foreseeable future.
| | | Deeper Medicare fee cut is imminent: Will Congress block it?
| | | By
Bob Gatty
| | | Unless Congress steps in again, physicians participating in the Medicare program will see their fees reduced by an average of 9.9% for 2008, a move that already has prompted a call for action from the American Medical Association.
| | | Three generations, very different practice styles
| | | By
Neil H. Baum, MD
,
Robert A. Dowling, MD
| | | Many challenges face the group urology practice, but one issue that doesn't get much attention is the cultural challenge of mixing physicians from different generations.
| |
| | | | New Products & Services
| | | Mountain View, CA—Percutaneous Systems' telescopic PercSys Accordion stone management device is a microcatheter equipped with a multi-fold film occlusion at the distal end. Once deployed, the occlusion conforms to and fills the ureter, preventing retrograde stone fragment migration into the kidney.
| |
|
|
| 
Practice Tools
